ST. PAUL, Minn.--(BUSINESS WIRE)--Angeion Corporation (NASDAQ: ANGN) today announced that it has launched its Physician Office Program for chronic obstructive pulmonary disease (COPD) and asthma management. Through aggressive, targeted marketing efforts, Angeion will work to increase physician awareness of COPD and the company’s non-invasive cardiorespiratory systems that facilitate early diagnosis—and treatment—of the condition.
